INVESTOR ALERT: Investigation of Taro Pharmaceutical Industries Ltd. Announced by Law Offices of Howard G. Smith

BENSALEM, Pa.--()--Law Offices of Howard G. Smith announces an investigation on behalf of investors of Taro Pharmaceutical Industries Ltd. (“Taro Pharmaceutical” or the “Company”) (NYSE:TARO) concerning the Company and its officers’ possible violations of federal securities laws.

On September 9, 2016, Taro Pharmaceutical disclosed it and two of its senior officers received grand jury subpoenas in connection with a federal antitrust investigation into generic drug pricing. On this news, shares of Taro Pharmaceutical fell 4% on September 12, 2016.

If you purchased Taro Pharmaceutical securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Recent Stories

RSS feed for Law Offices of Howard G. Smith

Release Summary

INVESTOR ALERT: Investigation of Taro Pharmaceutical Industries Ltd. Announced by Law Offices of Howard G. Smith

Law Offices of Howard G. Smith